Low-dose CBD products can go on sale over the counter in Australia from next year – but no smoking, vaping, topicals.
The Therapeutic Goods Administration (TGA) announced its decision on Tuesday 9 September, to make registered low-dose CBD products available for sale in Australian pharmacies from next year, as a Schedule 3 drug.
The decision had no major changes from the initial proposal made in April 2020 and opens the door for companies to apply for registration of their applicable products to be available over the counter in late 2021-2022.
The new regulations will allow the sale of registered pure CBD products (with 2% or less other cannabinoids) to adults in packets containing up to 1,800mg of CBD. This is 30 days supply of the recommended maximum daily dose of 60mg.
The announcement limited the products available to oral, oral mucosal and sublingual formulations only, ruling out vaping or topical cream products.
There was also an additional requirement that products be packaged securely and advertising to the general public will not be allowed.
Australian medical cannabis market experts, FreshLeaf Analytics, welcomed the decision, managing director, Cassandra Hunt, commented: “This will be the biggest thing to happen in the industry since legalisation of medicinal cannabis. We expect it will result in more Australians benefiting from the healing properties of cannabis and will reduce the number of people seeking products through unregulated illicit channels. The next challenge will be getting products in the market as quickly and cost effectively as possible.”
There are currently 17 low-dose CBD products available via the SAS-B and Authorised Prescriber pathways in Australia, with CBD products currently making up about 40 percent of all medicinal cannabis prescriptions.
FreshLeaf expects the over-the-counter CBD market to grow rapidly and exceed $200 million of revenue.
“We believe low dose CBD will become the largest market in Australia for cannabis products, quickly generating revenue in the hundreds of millions of dollars. There is a significant opportunity here for product companies to supply high quality, low cost medicine to pharmacies,” said Tim Drury, director of Southern Cannabis Holdings.
Pharmacists will still need to consult with consumers to ensure they are aware of potential drug-drug interactions as CBD can affect the way certain other medications are metabolised.
Dr Melissa Benson, advisory board member of Applied Cannabis Research said: “This is a win for supporting further clinical research in the area of low dose CBD medicines. It could also promote greater safety for patients if it leads to less use of illicit CBD products, which can expose patients to potential harms associated with unregulated products including contamination with heavy metals, pesticides and the like.”
However, Dr Mark Hardy, addiction specialist and CA Clinics medical advisory board member added: “This is a welcome move but it’s important to note that the effects of low-dose CBD may be negligible for many patients.
“Patients seeking treatment for chronic conditions that may benefit from medicinal cannabis may require higher dosages or other cannabinoids such as THC and should therefore consult their GP before taking these products, even in small amounts.”
The proposed implementation date has moved to 1 June 2021.
Meet the MEDA family: The smart way to drink
MEDA, the premium CBD functional wellness drink brand, founded by Adam Feldheim, has extended its range of products as part of an ambitious growth strategy.
The full range now incorporates NO-LO mixers and a new ready-to-pour vodka Espresso Medatini, as well as its original functional wellness drinks.
Feldheim, an entrepreneur with almost 20 years’ experience in corporate finance and global market research, discovered the benefits of CBD as part of a balanced lifestyle in his native California.
Identifying a gap in the market, pairing CBD with nootropics, adaptogens and other nutrients to promote wellness and wellbeing, MEDA was born in January 2019. In its first year of business MEDA has worked tirelessly to develop a premium lifestyle brand that provides targeted and game- changing wellness.
The CBD market, already mainstream in the USA, is currently valued at just over £325 million in the UK and predicted to increase to £1 billion by 2025.
The benefits of cannabinoids like CBD are extensive, with the primary function of supporting endocannabinoid health, helping those who consume it to achieve homeostasis.
MEDA has worked with Mary Biles and Clarsissa Lenherr, a respected CBD expert and leading nutritionist respectively, enabling the brand to be an informative voice in the emerging CBD and wellness space.
Focussing specifically on functionality and balance, each of its wellness drinks are made up of a unique set of ingredients
that are recognised for their functionalities. Examples of this include the use of Ashwagandha and Lemon balm in ‘Calm’, to help lower cortisol and reduce stress; In ‘Recover,’ Turmeric and Vitamin D are added to improve muscle recovery and aid immunity.
Balance is also at the heart of the new NO-LO range. When mixed with spirits, MEDA NO-LO drinks provide a conscious alternative to the high sugar and calorific mixers that are commonly used, as well as the combination of CBD and alcohol providing additional benefits. The MEDA NO- LO mixers can also be enjoyed on their own, as a non- alcoholic drink.
Pre-bottled with premium vodka and ready-to-drink, The Medatini represents a twist on London’s most popular cocktail yet contains only half the sugar and calories of a standard espresso martini.
Created by Feldheim in collaboration with Luís Simões, former Beverage Director at Annabel’s in Mayfair, it guarantees a perfect pour and can be served traditionally in a martini glass or, for the summer, over ice as a refreshing, caffeinated CBD cocktail. Currently the range is available online directly via MEDA and in retail stockists including Planet Organic, As Nature Intended, Revital and Daylesford Organic.
It is also served in some of London’s leading bars and restaurants including The Birley Group, The Ivy Collection, Chiltern Firehouse, The Arts Club, Park Chinois and Aqua Shard. The range is made in the UK and is vegan, with fully recyclable packaging.
An ambitious brand, led by Feldheim along with a team of seasoned advisors, MEDA is set for a pivotal year ahead with further product launches, lifestyle partnerships and collaborations to be announced.
The team also have plans to release Mixology Experience packages which customers will be able to order from the website for same day delivery in London and next day delivery across the UK, perfect for the boom in at-home entertaining.
These will include MEDA NO-LO mixers, alcohol spirits, and garnishes for you to create your very own bar experience at home.
To buy the Functional Wellness range, MEDA NO-LO or the Espresso Medatini, or for more information please visit: medahuman.com/shop @medahuman
Home comforts – are CBD furnishings the next big thing?
The emerging market for CBD products offers major growth opportunities in the home furnishings industry, experts have said.
During Furniture Today’s Bedding Conference which was live streamed in the US, panelists introducing CBD products to the home furnishings marketplace, said they see the CBD category growing substantially in the years ahead.
Scott Carr, Malouf’s marketing director, said interest in CBD is on the upswing.
There are 6.4 million online searches for “CBD” or “cannabidiol” per month, and the US market for CBD products is projected to hit $20 billion by 2024. The global cannabis market is projected to be more than $40 billion by 2024, he said.
Malouf sees strong growth opportunities in the segment, which it entered earlier this year with a CBD pillow, offered with three options.
Susan Mathes, vice president of brand relations for Therapedic, the first Top 10 bedding producer to offer a CBD mattress line, also sees a major upside for the segment.
“Scientific studies show CBD benefits a number of conditions including pain, anxiety and sleep disorders,” she said.
“CBD products are gaining significant market share in all forms due to its benefits related to well-being.”
Mathes also said the category is a natural for bedding.
“With CBD being known to help with restlessness, calming and insomnia,” she said, “how could it not be good to put in a mattress?”
Therapedic’s b-calm mattress line features CBD infused in the quilt fabric and in a layer of graphite latex. It is available flat-packed or roll-packed, and offers several strong talking points for retail sales associates.
Mathes has a family tie to the CBD field: Her husband, Barry, is involved in the manufacture of personal care CBD products for consumer products customers, and his work gave her insight into the field.
Also participating in the panel discussion was Shane Mutter, CEO of Seed2System, a CBD supplier based in Colorado.
“We start with premium seeds and we farm using organic practices,” he said.
“Our vertical supply chain yields consistent results with sustainable and scalable growth.”
He said Seed2System boasts a full line of CBD products, including tinctures, topical salves, edible salves, and gummies and honey sticks, with products for the bath, body and men’s categories.
Prior to his time in the hemp industry, Mutter was president and CEO of his family’s 80-plus-year-old home furnishings business on the outskirts of the French Quarter of New Orleans, Doerr Furniture.
Mutter said CBD’s appeal is broad, noting that youths, adults and seniors all benefit from CBD products.
Cannabis on demand – new delivery service launched in LA
A new free delivery service in Los Angeles is bringing high quality, legal cannabis products to customers on demand.
The new cannabis delivery service in the Los Angeles area last week, bringing fast and free delivery of high quality, legal cannabis products to customers.
Through Dyrect, which has been developed by a team of industry and business veterans from Ease, Medmen, Amazon, and Disney, customers can place orders and make payments through phone, text, or the company’s secure website at MyDyrect.com.
When orders are submitted, uniformed drivers deliver products directly from local, licensed dispensaries to customers in 30 minutes or less.
“The Dyrect mission is to provide the fastest on-demand delivery of cannabis products from licensed dispensaries throughout California, so consumers can feel confident that they’ll get exactly what they need from a wide variety of products all of which are delivered directly to them with no added fees,” explains Dyrect founder Chloe Parker.
“We have a vision to be the fastest delivery platform and the most user-centric in the United States by elevating the cannabis delivery customer experience through our focus on authentic low prices, quality assurance, and timely deliveries.
“That vision shows in everything we do – from our uniformed delivery team to the beautiful packaging and bags that we use. Every order is delivered in our premium holographic and branded bag. The recognizable and unique bag is a $10 value included at no charge.”
Dyrect also offers a generous discount program when something keeps a driver from delivering an order in a timely manner.
Chloe explained: “If Dyrect doesn’t deliver in 30 minutes or less, the customer gets a coupon for $30 off their next purchase.
“That’s how seriously we take our fast delivery promise.”
A customer service support team will be available from 10am-10pm every day answering questions and concerns.
“There really is no reason to go to a dispensary when customers can get the same reliable service and no added fees without leaving their homes,” added Chloe.
“Since the Dyrect cannabis delivery service connects customers directly to local dispensaries, there is no safer way to shop and buy in today’s environment.”
- Cancer survivor claims cannabis oil helped her beat brain tumour
- Labour MPs call for possible regulation of a legalised cannabis market
- CBD in Europe – what does the future look like?
- ‘Failure’ to embrace medical cannabis has caused “preventable deaths” – report
- “I’m not a bad person” – chronically ill woman convicted of growing medical cannabis
- Medical cannabis companies given green light for UK stock market in ‘long overdue’ move
Feature3 months ago
Medical cannabis could help long-term effects of COVID-19, says David Nutt
News2 months ago
NHS lines up cannabis medicine manufacturing
News1 week ago
Mum of three-year-old with ‘one in a million’ condition fights for medical cannabis funding
Case Studies6 months ago
CBD oil and fibromyalgia – a case study
Industry1 month ago
Building America’s biggest hemp empire
News2 months ago
Gut health and CBD – study
News2 months ago
Researchers hail CBN breakthrough
News2 weeks ago
Over one million patients eligible for new medical cannabis exemption card